Company Filing History:
1 out of 15 
1 out of 4 Years Active: 2012
Title: Innovations of Enrique Perez Paya
Introduction
Enrique Perez Paya is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents against retroviral infections.
Latest Patents
One of his key patents is focused on non-proteolysable oligopeptides that inhibit glycoprotein GP41 of the AIDS virus. This invention identifies oligopeptides, especially hexapeptides, that can inhibit the binding of retroviruses to target cells. The D-hexapeptides developed by Perez Paya offer potential novel therapies against infections from the human immunodeficiency virus (HIV). These compounds can be utilized as prophylactic or therapeutic agents for retroviral infections, particularly HIV-1.
Career Highlights
Throughout his career, Enrique Perez Paya has worked with prestigious institutions such as the Universidad del País Vasco and the Universidad de Valencia. His research has focused on innovative solutions to combat viral infections, showcasing his dedication to advancing medical science.
Collaborations
He has collaborated with notable colleagues, including Jose Luis Nieva Escandon and Maria Jose Gomara Elena, contributing to the advancement of research in his field.
Conclusion
Enrique Perez Paya's work in developing oligopeptides as therapeutic agents against HIV highlights his innovative spirit and commitment to improving healthcare. His contributions continue to inspire future research in the fight against viral infections.